We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BLTE market cap is 2.34B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.87M | -10.96M | -6.96M | -8.33M | -10.47M |
| Net Income | -6.81M | -10.94M | -6.99M | -7.87M | -9.49M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -5.74M | -9.8M | -12.82M | -31.67M |
| Net Income | -5.75M | -9.67M | -12.65M | -31.63M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 60.7M | 57.6M | 94.64M | 101.15M | 118.43M |
| Total Liabilities | 4.98M | 4.8M | 4.21M | 4.68M | 3.84M |
| Total Equity | 55.72M | 52.79M | 90.43M | 96.47M | 114.59M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.74M | 18.35M | 44.27M | 94.64M |
| Total Liabilities | 972k | 1.64M | 2.77M | 4.21M |
| Total Equity | -7.04M | -15.09M | 41.5M | 90.43M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | N/A | N/A | -29.84M | N/A | N/A |
| Investing | N/A | N/A | -63k | N/A | N/A |
| Financing | N/A | N/A | 75.96M | N/A | N/A |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.44M | -7.47M | -11.46M | -29.84M |
| Investing | -20k | -56k | -394k | -63k |
| Financing | 28.06M | -583k | 36.96M | 75.96M |
| Market Cap | 2.34B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 29.15M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 3.32 (4.05%) |
| Company Name | Belite Bio Inc |
| Address |
maples corporate services limited grand cayman KY1-1104 |
| Website | https://belitebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
